Tilray Brands, Inc.
General ticker "TLRY" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $869.7M (TTM average)
Tilray Brands, Inc. follows the US Stock Market performance with the rate: 41.2%.
Estimated limits based on current volatility of 7.1%: low 6.98$, high 8.05$
Factors to consider:
- Total employees count: 2650 (+65.6%) as of 2024
- US accounted for 29.6% of revenue in the fiscal year ended 2024-05-31
- Top business risk factors: Regulatory and compliance, Market competition, Litigation risks, Customer dependency, Cybersecurity threats
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-05-31 to 2027-05-31
- 2025-05-31 to 2026-05-31 estimated range: [3.22$, 9.93$]
- 2026-05-31 to 2027-05-31 estimated range: [3.09$, 8.92$]
Financial Metrics affecting the TLRY estimates:
- Positive: with PPE of -2.0 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -32.71 <= 0.33
- Positive: Inventory ratio change, % of 0.59 <= 0.84
- Positive: Shareholder equity ratio, % of 71.41 > 63.39
- Negative: negative Industry operating cash flow (median)
Short-term TLRY quotes
Long-term TLRY plot with estimates
Financial data
| YTD | 2023-05-31 | 2024-05-31 | 2025-05-31 |
|---|---|---|---|
| Operating Revenue | $844.72MM | $1,074.99MM | $1,126.99MM |
| Operating Expenses | $2,689.65MM | $1,313.09MM | $4,259.30MM |
| Operating Income | $-1,844.93MM | $-238.10MM | $-3,132.30MM |
| Non-Operating Income | $-108.43MM | $-101.20MM | $-26.99MM |
| Interest Expense | $62.79MM | $67.13MM | $56.71MM |
| R&D Expense | $0.92MM | $0.87MM | $0.39MM |
| Income(Loss) | $-1,953.36MM | $-339.31MM | $-3,159.29MM |
| Taxes | $-9.67MM | $-36.27MM | $-166.06MM |
| Profit(Loss)* | $-1,956.69MM | $-333.80MM | $-3,000.62MM |
| Stockholders Equity | $3,315.69MM | $3,442.91MM | $2,074.03MM |
| Inventory | $270.14MM | $343.49MM | $371.70MM |
| Assets | $4,307.26MM | $4,221.66MM | $2,904.47MM |
| Operating Cash Flow | $7.91MM | $-30.91MM | $-129.81MM |
| Capital expenditure | $28.02MM | $39.85MM | $45.17MM |
| Investing Cash Flow | $-285.11MM | $128.35MM | $-64.11MM |
| Financing Cash Flow | $70.16MM | $-75.19MM | $183.20MM |
| Earnings Per Share** | $-3.17 | $-0.45 | $-3.37 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.